Erasca Inc. (ERAS) NASDAQ
$2.05 (0.01) (-0.48%)
Market Cap: $311.24M
As of 03/28/24 03:59 PM EDT. Market closed.
Erasca Inc. (ERAS)
NASDAQ
$2.05
(0.01) (-0.48%)
Market Cap: $311.24M
As of 03/28/24 03:59 PM EDT. Market closed.
our mission at erasca is embedded in our name: to erase cancer in patients by creating a new generation of oncology drugs that we hope will not just treat, but actually cure. energized by recent scientific discoveries and advances in drugging various biological drivers of cancer, we are committed to solving oncology’s hardest problems. we have assembled a proven team and joined forces with ... read more
our mission at erasca is embedded in our name: to erase cancer in patients by creating a new generation of oncology drugs that we hope will not just treat, but actually cure. energized by recent scientific discoveries and advances in drugging various biological drivers of cancer, we are committed to solving oncology’s hardest problems. we have assembled a proven team and joined forces with world-class collaborators who embrace our ambitious goals. read less
Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
Chacko David M. | CFO and CBO | Dec 15, 2023 | Option Exercise | $1.59 | 7,478 | 11,886 | 246,726 | Dec 18, 2023, 09:14 AM |
Garner Ebun | General Counsel & Corp. Sec. | Dec 15, 2023 | Option Exercise | $1.59 | 5,448 | 8,660 | 9,728 | Dec 18, 2023, 09:13 AM |
Start Valerie Denise Harding | Director | Dec 06, 2023 | Buy | $1.85 | 10,000 | 18,480 | 20,000 | Dec 08, 2023, 09:10 AM |
Lim Jonathan E | Chairman & CEO | Dec 06, 2023 | Buy | $1.72 | 278,150 | 478,418 | 12,899,360 | Dec 06, 2023, 07:41 PM |
Lim Jonathan E | Chairman & CEO | Dec 05, 2023 | Buy | $1.69 | 721,850 | 1,217,761 | 12,899,360 | Dec 06, 2023, 07:41 PM |
Casdin Alexander W. | Director | Dec 04, 2023 | Buy | $1.66 | 30,000 | 49,785 | 493,974 | Dec 04, 2023, 06:23 PM |
Lim Jonathan E | Chairman & CEO | Oct 05, 2023 | Buy | $2.03 | 1,000,000 | 2,026,000 | 19,456,216 | Oct 10, 2023, 08:00 AM |
Lim Jonathan E | Chairman & CEO | Jun 08, 2023 | Buy | $2.75 | 100,000 | 275,000 | 18,396,216 | Jun 08, 2023, 08:54 PM |
Casdin Alexander W. | Director | Apr 10, 2023 | Buy | $2.76 | 20,000 | 55,230 | 463,974 | Apr 11, 2023, 08:23 AM |
Lim Jonathan E | Chairman & CEO | Mar 28, 2023 | Buy | $2.84 | 100,000 | 284,000 | 18,296,216 | Mar 28, 2023, 09:24 PM |
Chacko David M. | Chief Financial Officer | Feb 01, 2023 | Option Exercise | $4.10 | 1,750 | 7,169 | 239,248 | Feb 03, 2023, 08:54 AM |
Wei Lin | Chief Medical Officer | Feb 01, 2023 | Option Exercise | $4.10 | 1,750 | 7,169 | 315,812 | Feb 03, 2023, 08:53 AM |
Garner Ebun | General Counsel & Corp. Sec. | Feb 01, 2023 | Option Exercise | $4.10 | 2,390 | 9,791 | 4,280 | Feb 03, 2023, 08:53 AM |
Lim Jonathan E | Chairman & CEO | Jan 10, 2023 | Buy | $3.86 | 60,000 | 231,420 | 20,256,222 | Jan 10, 2023, 04:46 PM |
Start Valerie Denise Harding | Director | Dec 21, 2022 | Buy | $4.64 | 10,000 | 46,400 | 10,000 | Dec 22, 2022, 09:28 PM |
Bristol James Arthur | Director | Dec 21, 2022 | Buy | $4.14 | 20,000 | 82,800 | 20,000 | Dec 22, 2022, 09:26 PM |
Chen Bihua | Director | Dec 13, 2022 | Buy | $6.50 | 307,692 | 1,999,998 | 10,813,246 | Dec 21, 2022, 04:33 PM |
Chen Bihua | Director | Dec 13, 2022 | Buy | $6.50 | 307,692 | 1,999,998 | 10,813,246 | Dec 20, 2022, 05:42 PM |
Casdin Alexander W. | Director | Dec 15, 2022 | Buy | $4.87 | 20,000 | 97,490 | 443,974 | Dec 15, 2022, 04:47 PM |
Lim Jonathan E | Chairman & CEO | Dec 14, 2022 | Buy | $4.99 | 40,000 | 199,600 | 20,196,222 | Dec 15, 2022, 11:53 AM |
Garner Ebun | General Counsel & Corp. Sec. | Feb 01, 2022 | Option Exercise | $11.60 | 990 | 11,486 | 1,890 | Feb 03, 2022, 07:56 PM |
Wei Lin | Chief Medical Officer | Feb 01, 2022 | Option Exercise | $11.60 | 1,562 | 18,123 | 314,062 | Feb 03, 2022, 07:54 PM |
Chacko David M. | Chief Financial Officer | Feb 01, 2022 | Option Exercise | $11.60 | 1,562 | 18,123 | 237,498 | Feb 03, 2022, 07:39 PM |
Chen Bihua | Director | Aug 10, 2021 | Buy | $22.10 | 200,000 | 4,420,000 | 10,505,553 | Aug 10, 2021, 04:02 PM |
Chen Bihua | Director | Jul 26, 2021 | Sale | $18.76 | 200,000 | 3,753,000 | 10,305,553 | Aug 10, 2021, 04:02 PM |
Chen Bihua | Director | Jul 20, 2021 | Buy | $16.00 | 950,000 | 15,200,000 | 10,505,553 | Jul 22, 2021, 04:10 PM |
Garner Ebun | General Counsel | Jul 20, 2021 | Buy | $16.00 | 900 | 14,400 | 900 | Jul 20, 2021, 08:57 PM |
Start Valerie Denise Harding | Director | Jul 20, 2021 | Buy | $16.00 | 2,000 | 32,000 | 2,000 | Jul 20, 2021, 08:49 PM |
Multani Pratik S | Director | Jul 20, 2021 | Buy | $16.00 | 6,200 | 99,200 | 172,866 | Jul 20, 2021, 08:46 PM |
Hambleton Julie | Director | Jul 20, 2021 | Buy | $16.00 | 6,000 | 96,000 | 6,000 | Jul 20, 2021, 08:43 PM |
Owner | Relationship | Date | Value($) |
Chacko David M. | CFO and CBO | 12/15/2023 | 11,886 |
Garner Ebun | General Counsel & Corp. Sec. | 12/15/2023 | 8,660 |
Start Valerie Denise Harding | Director | 12/06/2023 | 18,480 |
Lim Jonathan E | Chairman & CEO | 12/06/2023 | 478,418 |
Lim Jonathan E | Chairman & CEO | 12/05/2023 | 1,217,761 |
Casdin Alexander W. | Director | 12/04/2023 | 49,785 |
Lim Jonathan E | Chairman & CEO | 10/05/2023 | 2,026,000 |
Lim Jonathan E | Chairman & CEO | 06/08/2023 | 275,000 |
Casdin Alexander W. | Director | 04/10/2023 | 55,230 |
Lim Jonathan E | Chairman & CEO | 03/28/2023 | 284,000 |
Chacko David M. | Chief Financial Officer | 02/01/2023 | 7,169 |
Wei Lin | Chief Medical Officer | 02/01/2023 | 7,169 |
Garner Ebun | General Counsel & Corp. Sec. | 02/01/2023 | 9,791 |
Lim Jonathan E | Chairman & CEO | 01/10/2023 | 231,420 |
Start Valerie Denise Harding | Director | 12/21/2022 | 46,400 |
Bristol James Arthur | Director | 12/21/2022 | 82,800 |
Chen Bihua | Director | 12/13/2022 | 1,999,998 |
Chen Bihua | Director | 12/13/2022 | 1,999,998 |
Casdin Alexander W. | Director | 12/15/2022 | 97,490 |
Lim Jonathan E | Chairman & CEO | 12/14/2022 | 199,600 |
Garner Ebun | General Counsel & Corp. Sec. | 02/01/2022 | 11,486 |
Wei Lin | Chief Medical Officer | 02/01/2022 | 18,123 |
Chacko David M. | Chief Financial Officer | 02/01/2022 | 18,123 |
Chen Bihua | Director | 08/10/2021 | 4,420,000 |
Chen Bihua | Director | 07/26/2021 | 3,753,000 |
Chen Bihua | Director | 07/20/2021 | 15,200,000 |
Garner Ebun | General Counsel | 07/20/2021 | 14,400 |
Start Valerie Denise Harding | Director | 07/20/2021 | 32,000 |
Multani Pratik S | Director | 07/20/2021 | 99,200 |
Hambleton Julie | Director | 07/20/2021 | 96,000 |
Fund | # Shares Owned | % of Portfolio | % Change | Investing Style |
---|---|---|---|---|
BLACKROCK INC. | 7,310,321 | 0.0004% | 4.03% | Other |
RENAISSANCE TECHNOLOGIES LLC | 2,008,500 | 0.00662% | 170.65% | Other |
GEODE CAPITAL MANAGEMENT, LLC | 1,811,911 | 0.0004% | 5.63% | Other |
D. E. SHAW & CO., INC. | 102,243 | 0.00019% | New | Other |
AQR CAPITAL MANAGEMENT LLC | 13,058 | 0.00005% | Exited | Other |
Period of Report: 12/31/2023
10-K/10-Q Filings: View